UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): December 21, 2015

 

mPHASE TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in Charter)

 

New Jersey		000-24969		22-2287503
(State or Other Jurisdiction of		(Commission File Number)		(IRS Employer
Identification No.)				Incorporation)

 

587 Connecticut Ave., Norwalk, CT 06854-0566

(Address of Principal Executive Offices) (ZIP Code)

Registrant's telephone number, including area code: (203) 838-2741

Item 8.01 Other Events

On December 19, 2015 mPhase Technologies, Inc. (the “Company”) received a Notice of Allowance of a Patent covering a Drug Delivery System from the United States Patent and Trademark Office.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	mPHASE TECHNOLOGIES
Date: December 22, 2015	By:	/s/ Martin S. Smiley
		Martin S. Smiley
		Executive Vice President,
		Chief Financial Officer and
		General Counsel

 

3